The News Feed

Pharmaceuticals

TNS Safe Treatment for Ocular Pain

Study suggests three- to six-month use of a trigeminal neurostimulator decreased eye pain, light and wind sensitivity, and burning sensations.
June 1, 2021

2021 ARMOR Results Find Staph Resistance Still Problematic

However, S. aureus had a significant decrease in methicillin resistance.
May 4, 2021

Economic Burden Worsens for Glaucoma Patients

Studies found additional IOP-lowering drops led to higher costs with only short-term benefits and observed a spike in brand name med prices.
March 24, 2021

Atropine Penetration Minimally Affected by Preservatives

Stability and safety of the drug are better predictors of successful outcomes.
February 16, 2021

Glaucoma Patients More Likely to Respond to Steroids

However, longer axial length and a heavier medication burden may decrease the effectiveness of therapy post-op.
February 9, 2021

Mississippi Pushes for Expanded Scope of Practice

Proposal includes oral steroids, lid lesion care and laser capsulotomy privileges.
February 9, 2021

Diabetes Drug Protects Against AMD

Low to moderate doses of metformin demonstrated decreased odds ratios in patients without DR.
February 8, 2021

Most Systemic Meds Don’t Trigger GA in AMD Patients

However, calcium channel blockers may cause faster retinal cell atrophy.
December 30, 2020

Steroid Approved for Dry Eye

A two-week course of therapy with Eysuvis improved signs and symptoms.
October 27, 2020

Eye Drop for Presbyopia Moves Through Trials

Distance-corrected near visual acuity gains show the potential of this new method of correction.
October 12, 2020